Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Melissa Brown, managing director of applied research with Qontigo, joined Cheddar News to discuss a new start to the trading week as the market edged lower in a mixed-performance day. Investors also await the meeting between President Joe Biden and House Speaker Kevin McCarthy to look to resolve its debt ceiling debate.
Bobbi Rebell, chief financial officer of Financial Wellness Strategies and author of Launching Financial Grownups: Live Your Richest Life by Helping Your (Almost) Adult Kids Become Everyday Money Smart, gives the top four reasons people struggle financially.
Warren Buffett criticized how regulators and lawmakers have handled recent bank failures and noted that the ongoing debt ceiling showdown will sow even more chaos.
Wall Street drifted to a mixed close ahead of a week full of reports on some of the market’s biggest worries, including how stubbornly high inflation remains across the economy.
